237 related articles for article (PubMed ID: 26526073)
1. Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions.
Arimany-Nardi C; Koepsell H; Pastor-Anglada M
Pharmacogenomics J; 2015 Dec; 15(6):473-87. PubMed ID: 26526073
[TBL] [Abstract][Full Text] [Related]
2. Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells.
Arimany-Nardi C; Montraveta A; Lee-Vergés E; Puente XS; Koepsell H; Campo E; Colomer D; Pastor-Anglada M
Pharmacogenomics J; 2015 Aug; 15(4):363-71. PubMed ID: 25582574
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms affecting function of the human organic cation transporter hOCT1 (SLC22A1): what are the consequences?
Schinkel AH; Jonker JW
Pharmacogenetics; 2002 Nov; 12(8):589-90. PubMed ID: 12439217
[No Abstract] [Full Text] [Related]
4. Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions.
Arimany-Nardi C; Minuesa G; Keller T; Erkizia I; Koepsell H; Martinez-Picado J; Pastor-Anglada M
Front Pharmacol; 2016; 7():175. PubMed ID: 27445813
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2.
Hendrickx R; Johansson JG; Lohmann C; Jenvert RM; Blomgren A; Börjesson L; Gustavsson L
J Med Chem; 2013 Sep; 56(18):7232-42. PubMed ID: 23984907
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of drug transporters in the enterohepatic circulation.
Stieger B; Meier PJ
Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
[TBL] [Abstract][Full Text] [Related]
7. Emerging Clinical Importance of Hepatic Organic Cation Transporter 1 (OCT1) in Drug Pharmacokinetics, Dynamics, Pharmacogenetic Variability, and Drug Interactions.
Zamek-Gliszczynski MJ; Giacomini KM; Zhang L
Clin Pharmacol Ther; 2018 May; 103(5):758-760. PubMed ID: 29193038
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of the organic cation transporter 1 gene (SLC22A1) within the Cape Admixed population of South Africa.
Du Plessis M; Pearce B; Jacobs C; Hoosain N; Benjeddou M
Mol Biol Rep; 2015 Mar; 42(3):665-72. PubMed ID: 25398212
[TBL] [Abstract][Full Text] [Related]
9. The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha.
Saborowski M; Kullak-Ublick GA; Eloranta JJ
J Pharmacol Exp Ther; 2006 May; 317(2):778-85. PubMed ID: 16436500
[TBL] [Abstract][Full Text] [Related]
10. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
Bourdet DL; Pritchard JB; Thakker DR
J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
[TBL] [Abstract][Full Text] [Related]
11. OCT1 pharmacogenetics in pain management: is a clinical application within reach?
Tzvetkov MV
Pharmacogenomics; 2017 Nov; 18(16):1515-1523. PubMed ID: 29061087
[TBL] [Abstract][Full Text] [Related]
12. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the human organic cation transporter hOCT1.
Ciarimboli G; Struwe K; Arndt P; Gorboulev V; Koepsell H; Schlatter E; Hirsch JR
J Cell Physiol; 2004 Dec; 201(3):420-8. PubMed ID: 15389554
[TBL] [Abstract][Full Text] [Related]
14. Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences.
Kerb R; Brinkmann U; Chatskaia N; Gorbunov D; Gorboulev V; Mornhinweg E; Keil A; Eichelbaum M; Koepsell H
Pharmacogenetics; 2002 Nov; 12(8):591-5. PubMed ID: 12439218
[TBL] [Abstract][Full Text] [Related]
15. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
[TBL] [Abstract][Full Text] [Related]
16. Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin.
Choi MK; Jin QR; Jin HE; Shim CK; Cho DY; Shin JG; Song IS
Biopharm Drug Dispos; 2007 Dec; 28(9):501-10. PubMed ID: 17876861
[TBL] [Abstract][Full Text] [Related]
17. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
18. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
Kimura N; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
[TBL] [Abstract][Full Text] [Related]
19. The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia.
Di Paolo A; Polillo M; Capecchi M; Cervetti G; Baratè C; Angelini S; Guerrini F; Fontanelli G; Arici R; Ciabatti E; Grassi S; Bocci G; Hrelia P; Danesi R; Petrini M; Galimberti S
Pharmacogenomics J; 2014 Aug; 14(4):328-35. PubMed ID: 24589908
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
Oscarson M
Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
